ArticlePloS one2013

Biomarker report from the phase II lamotrigine trial in secondary progressive MS - neurofilament as a surrogate of disease progression.

Sharmilee Gnanapavan et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.